These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 37581323)

  • 1. The HPA Axis as Target for Depression.
    Menke A
    Curr Neuropharmacol; 2024; 22(5):904-915. PubMed ID: 37581323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin V1B Receptor Antagonists as Potential Antidepressants.
    Chaki S
    Int J Neuropsychopharmacol; 2021 Jul; 24(6):450-463. PubMed ID: 33733667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood mRNA expression levels of glucocorticoid receptors and FKBP5 are associated with depressive disorder and altered HPA axis.
    Hori H; Yoshida F; Ishida I; Matsuo J; Ogawa S; Hattori K; Kim Y; Kunugi H
    J Affect Disord; 2024 Mar; 349():244-253. PubMed ID: 38199409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.
    Scott LV; Dinan TG
    Life Sci; 1998; 62(22):1985-98. PubMed ID: 9627097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing hormone and the hypothalamic-pituitary-adrenal axis in psychiatric disease.
    Naughton M; Dinan TG; Scott LV
    Handb Clin Neurol; 2014; 124():69-91. PubMed ID: 25248580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptides and the hypothalamic-pituitary-adrenocortical (HPA) system: review of recent research strategies in depression.
    Hatzinger M
    World J Biol Psychiatry; 2000 Apr; 1(2):105-11. PubMed ID: 12607206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to measure glucocorticoid receptor's sensitivity in patients with stress-related psychiatric disorders.
    Leistner C; Menke A
    Psychoneuroendocrinology; 2018 May; 91():235-260. PubMed ID: 29449045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone corticotropin releasing hormone test in healthy and depressed women with and without childhood adversity.
    Spitzer C; Otte C; Kuehl LK; May A; Schultebraucks K; Hellmann-Regen J; Wingenfeld K
    Psychoneuroendocrinology; 2018 Jan; 87():147-151. PubMed ID: 29080551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between hypothalamic-pituitary-adrenal axis dysregulation and insulin resistance in elderly patients with depression.
    Yokoyama K; Yamada T; Mitani H; Yamada S; Pu S; Yamanashi T; Matsumura H; Nakagome K; Kaneko K
    Psychiatry Res; 2015 Apr; 226(2-3):494-8. PubMed ID: 25757913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
    Kunugi H; Ida I; Owashi T; Kimura M; Inoue Y; Nakagawa S; Yabana T; Urushibara T; Kanai R; Aihara M; Yuuki N; Otsubo T; Oshima A; Kudo K; Inoue T; Kitaichi Y; Shirakawa O; Isogawa K; Nagayama H; Kamijima K; Nanko S; Kanba S; Higuchi T; Mikuni M
    Neuropsychopharmacology; 2006 Jan; 31(1):212-20. PubMed ID: 16123748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisol response patterns in depressed women and their healthy daughters at risk: Comparison with healthy women and their daughters.
    Gonul AS; Cetinkalp S; Tunay S; Polat I; Simsek F; Aksoy B; Kizilates G; Erdogan Y; Coburn KL
    J Psychiatr Res; 2017 Feb; 85():66-74. PubMed ID: 27837659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior.
    Sher L
    ScientificWorldJournal; 2006 Oct; 6():1398-404. PubMed ID: 17086345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-trans retinoic acid-induced hypothalamus-pituitary-adrenal hyperactivity involves glucocorticoid receptor dysregulation.
    Hu P; Liu J; Zhao J; Qi XR; Qi CC; Lucassen PJ; Zhou JN
    Transl Psychiatry; 2013 Dec; 3(12):e336. PubMed ID: 24346134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the HPA Axis as Target for Depression Outdated, or Is There a New Hope?
    Menke A
    Front Psychiatry; 2019; 10():101. PubMed ID: 30890970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic-pituitary-adrenal axis and depression symptom effects of an arginine vasopressin type 1B receptor antagonist in a one-week randomized Phase 1b trial.
    Katz DA; Locke C; Greco N; Liu W; Tracy KA
    Brain Behav; 2017 Mar; 7(3):e00628. PubMed ID: 28293470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression.
    Behnken A; Bellingrath S; Symanczik JP; Rieck MJ; Zavorotnyy M; Domschke K; Arolt V; Zwanzger P
    Psychoneuroendocrinology; 2013 Mar; 38(3):447-54. PubMed ID: 22840287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
    Chang HS; Won E; Lee HY; Ham BJ; Lee MS
    Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.